HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics.
来源：PubMed发布日期：2026-08-07作者：Mafham M, Zayed M, Collins R, Sabatine M, Armitage J1 次点击